SID 791

Known as: SID-791, SID791 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1981-2017
012319812017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Quantitative measurement of the major regulatory proteins in signaling networks poses several technical challenges, including low… (More)
Is this relevant?
2013
2013
Easily measurable biomarkers are urgently required to detect early stages of cancer progression. Autoantibodies (aAbs), as a… (More)
  • figure 1
  • table 1
  • figure 3
  • table 2
  • figure 4
Is this relevant?
2011
2011
  • 2011
The compelling need for establishing the identity of a person is becoming critical in our vastly interconnected society… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2009
2009
Improvement James McNerney ∗ †, J. Doyne Farmer ∗ ‡, Sid Redner ∗ † §, and Jessika E Trancik ∗ ¶ ∗Santa Fe Institute, 1399 Hyde… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2009
2009
The suppression of the abundant water signal has been tradi tionally employed to decrease the dynamic range of the NMR signal in… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2005
2005
The initial positioning of anthropomorphic test devices (ATDs) can influence the outcomes of crash tests. Current procedures for… (More)
Is this relevant?
1999
1999
A controller for displaying restricted patterns in passive matrix LCDs will be presented. Hardware complexity and the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1996
1996
SID 791, a bicyclam inhibiting human immunodeficiency virus (HIV) replication in vitro by blocking virus entry into cells, is an… (More)
Is this relevant?
1996
1996
Bicyclams are a novel class of antiviral compounds which act as potent and selective inhibitors of the replication of human… (More)
Is this relevant?
1996
1996
The bicyclams represent a new class of highly potent and selective HIV inhibitors. Time-of-addition experiments have previously… (More)
Is this relevant?